Perineural invasion in radical prostatectomy specimens: lack of prognostic significance
- PMID: 15538241
- DOI: 10.1097/01.ju.0000143973.22897.f8
Perineural invasion in radical prostatectomy specimens: lack of prognostic significance
Abstract
Purpose: The prognostic significance of perineural invasion in radical prostatectomy specimens is uncertain. We evaluated the relationship between perineural invasion and other pathological characteristics in whole mount radical retropubic prostatectomy specimens as well as prostate specific antigen (PSA) recurrence postoperatively.
Materials and methods: Between 1999 and 2003, 364 consecutive patients were treated with radical prostatectomy for localized prostate cancer. Radical prostatectomy specimens were processed by the whole mount technique. The relationship of perineural invasion and various clinicopathological characteristics to PSA recurrence was analyzed.
Results: Perineural invasion was present in 287 specimens (79%). Specimens with perineural invasion were associated with smaller prostate weight (p <0.0001), greater pathological stage (p <0.0001), larger tumor volume (p <0.0001), higher Gleason score (p <0.0001), a higher incidence of extraprostatic extension (p <0.0001) and seminal vesicle invasion (p = 0.02), and a higher positive surgical margin rate (p = 0.01). Perineural invasion did not correlate with preoperative PSA (p = 0.96), lymph node metastases (p = 0.35), multifocality (p = 0.21), high grade prostatic intraepithelial neoplasia (p = 0.12) or PSA recurrence (p = 0.24).
Conclusions: While perineural invasion in the radical prostatectomy specimen significantly correlated with multiple adverse pathological factors, it did not predict which patients will have early PSA recurrence following radical prostatectomy.
Similar articles
-
The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.Hum Pathol. 2007 Aug;38(8):1207-11. doi: 10.1016/j.humpath.2007.01.006. Epub 2007 May 8. Hum Pathol. 2007. PMID: 17490720
-
Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.Am J Surg Pathol. 1997 Dec;21(12):1496-500. doi: 10.1097/00000478-199712000-00013. Am J Surg Pathol. 1997. PMID: 9414194
-
Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?J Urol. 1999 Jul;162(1):103-6. doi: 10.1097/00005392-199907000-00025. J Urol. 1999. PMID: 10379750
-
The role of perineural invasion and other biopsy characteristics as prognostic markers for localized prostate cancer.Semin Urol Oncol. 1998 Aug;16(3):124-8. Semin Urol Oncol. 1998. PMID: 9741416 Review.
-
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.Scand J Urol Nephrol Suppl. 2005 May;(216):34-63. doi: 10.1080/03008880510030932. Scand J Urol Nephrol Suppl. 2005. PMID: 16019758 Review.
Cited by
-
Perineural Invasion and Risk of Lethal Prostate Cancer.Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):719-726. doi: 10.1158/1055-9965.EPI-16-0237. Epub 2017 Jan 6. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28062398 Free PMC article.
-
Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi-institutional analysis.Cancer Med. 2020 May;9(10):3383-3389. doi: 10.1002/cam4.2920. Epub 2020 Mar 18. Cancer Med. 2020. PMID: 32187859 Free PMC article.
-
Biological correlates of prostate cancer perineural invasion diameter.Hum Pathol. 2014 Jul;45(7):1365-9. doi: 10.1016/j.humpath.2014.02.011. Epub 2014 Feb 28. Hum Pathol. 2014. PMID: 24768607 Free PMC article.
-
Prognostic determinants in prostate cancer.Cancer J. 2011 Nov-Dec;17(6):429-37. doi: 10.1097/PPO.0b013e31823b042c. Cancer J. 2011. PMID: 22157287 Free PMC article. Review.
-
Clinicopathological factors associated with pathological upgrading from biopsy to prostatectomy in patients with ISUP grade group ≤2 prostate cancer.Asian J Androl. 2022 Sep-Oct;24(5):487-493. doi: 10.4103/aja2021108. Asian J Androl. 2022. PMID: 35170453 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous